Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
about
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysisA microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma.Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.A statin-regulated microRNA represses human c-Myc expression and function.miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47Genetic grouping of medulloblastomas by representative markers in pathologic diagnosis.Role of MYC in Medulloblastoma.Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.Cytogenetic prognostication within medulloblastoma subgroups.Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival.Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations.Medulloblastoma: selecting children for reduced treatment.SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.Novel gene expression model for outcome prediction in paediatric medulloblastoma.Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors.
P2860
Q33592683-5AFB2386-88DA-49F7-9416-C7FE64F453FCQ34457533-8F0B4B08-2D51-4B10-B013-45AE86485325Q34610115-665A5CE6-9DA8-43EC-8206-9D9675C39C01Q35550246-0A1AC554-8097-4779-86A2-5F96193C1A63Q36379501-B89E1B72-CA78-490C-B9E7-174831ECF95AQ36685489-4CDA9DFF-8041-4B0C-8974-24B211C4D305Q36865020-4682B93F-CAE5-4DD3-8E6B-61E9CBA19977Q37256443-74601AFE-7A2D-4F50-97FC-E15C64435FAAQ37452592-719708C0-19A2-4461-9B04-4520F5D2A348Q37627692-CDE2E256-363D-4F99-83ED-1B84F2FBB5A8Q44597088-3E950191-9EAB-437B-B1C9-FA7E76B6B0EDQ47363064-42CCB073-74B9-451B-BEFB-35396D7E45C3Q47951881-6F8F5C16-D049-4365-93E2-C61C3E5FF588Q50604253-7BE63A38-A8CC-4C87-9368-834FACB9BD52Q50673128-23FDB897-60BF-4D87-B44E-0370F4870075Q51015416-1AA9D563-82DF-4F90-9C68-CB9FE6966290Q54237934-9F01BBD0-93D8-47E8-B029-3DE81F773318Q55136092-CB3A4815-693E-4628-BC50-08A0E327D8DA
P2860
Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prognostic classification of p ...... N, and Wnt pathway activation.
@ast
Prognostic classification of p ...... N, and Wnt pathway activation.
@en
type
label
Prognostic classification of p ...... N, and Wnt pathway activation.
@ast
Prognostic classification of p ...... N, and Wnt pathway activation.
@en
prefLabel
Prognostic classification of p ...... N, and Wnt pathway activation.
@ast
Prognostic classification of p ...... N, and Wnt pathway activation.
@en
P2093
P2860
P50
P356
P1433
P1476
Prognostic classification of p ...... N, and Wnt pathway activation.
@en
P2093
Ae Kyung Park
Byung-Kyu Cho
Christelle Dufour
Christian Sainte-Rose
Christine Haberler
Dong Gyu Kim
Ji Hoon Phi
Kyu-Chang Wang
Sarah Fattet
Seung-Jun Lee
P2860
P304
P356
10.1093/NEUONC/NOR196
P577
2011-11-16T00:00:00Z